Binocular Wavefront Optometry Machine
Nantong, Jiangsu, 226001, China
Location status: Recruiting
NCT Number: NCT07146828
In recent years, the incidence of myopia has been high globally and is exhibiting a rapid upward trend, with projections estimating it will reach 49.8% by 2050. Corneal refractive surgery has become a primary method for correcting myopia, demonstrating significant efficacy and favorable safety. However, studies indicate that overcorrection or undercorrection can occur following refractive surgery. Reports have shown that three months post-SMILE surgery, 20% of eyes had residual refractive errors ≥ 0.50 D, and 6% had errors ≥ 1.00 D. We hypothesize that this may be related to imprecise preoperative refraction, subsequently affecting postoperative visual quality.
Due to limitations in lens manufacturing precision, the widely used increment for sphere correction remains 0.25 D. However, this may prevent some patients from achieving their optimal corrected state. Studies have reported that 95% of individuals are sensitive to diopter changes below 0.25 D, and 44% can distinguish changes smaller than 0.125 D. Other research suggests that adjusting spherical power in 0.05 D increments yields better corrected visual acuity. Furthermore, scholars have reported that 0.05 D precision refraction can significantly improve the red-green balance test rate, enabling myopic patients to achieve better visual quality. Therefore, improving refraction precision could provide patients with superior visual outcomes.
Currently, the Binocular Wavefront Optometry Machine (BWFOM, Ai-Zhitong Medical Technology Co., Ltd., Zhejiang, China) can perform objective and subjective refraction with 0.05 D increments for both sphere and cylinder correction, while also separately measuring higher-order aberrations (HOAs) and lower-order aberrations (LOAs). Given the scarcity of research on the outcomes of 0.05 D refraction for SMILE and FS-LASIK procedures, this study aims to evaluate visual acuity, aberrations, and refractive status in patients following SMILE and FS-LASIK surgery. The primary objective is to investigate whether preoperative 0.05 D precision refraction using the BWFOM can enhance postoperative visual quality for SMILE and FS-LASIK patients.
Interested in participating?
Request Info18 year–40 year
All sexes
Interventional
Not applicable
Nantong, Jiangsu, 226001, China
Location status: Recruiting
This study aims to optimize the surgical parameters of corneal refractive surgery (SMILE and FS-LASIK) by utilizing 0.05 D high-precision refraction achieved through a binocular wavefront aberrometer, thereby improving patients' postoperative visual outcomes. The prospective study design involves patients scheduled for corneal refractive surgery at our hospital.
The research consists of two parts:
Part One: Performing 0.05 D precision refraction on myopic patients using the binocular wavefront aberrometer.
Part Two: Applying the obtained refraction results (in increments of 0.05 D) for refractive correction in patients undergoing SMILE and FS-LASIK surgery.
Specific procedures include:
Screening eligible patients who voluntarily choose SMILE or FS-LASIK. Preoperatively inputting the patients' 0.05 D refraction data into the SMILE platform (VisuMax Precision 4.0 - VISULYZE system) or the FS-LASIK system (applying the manufacturer-provided nomogram for undercorrection).
Utilizing the system-recommended input values for correcting refractive errors during surgery.
Conducting postoperative follow-up examinations at 10 days, 1 month, 3 months, 6 months, and 1 year.
Evaluation metrics include:
Postoperative uncorrected visual acuity (UCVA), best-corrected visual acuity (BCVA), spherical power, cylindrical power, spherical equivalent (SE), and aberrations.
Proportion of patients achieving postoperative UCVA ≥ 0.8, ≥ 1.0, and ≥ 1.2. Proportion of patients with postoperative SE within ±0.50 D and ±1.0 D. Proportion of patients with postoperative astigmatism (cylinder) within ±0.50 D and ±1.0 D.
Postoperative efficacy index and safety index.
Intraocular pressure (IOP). Anterior segment examination.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The 0.05 D refraction group had their infusion rates precisely calibrated using 0.05 D refraction by the Binocular Wavefront Optometry Machine
Time frame: Preoperatively, and at 1 day, 10 days, 1 month, 3 months, 6 months, and 1 year postoperatively
It calculated as: SE = Sphere + ½ Cylinder
Time frame: Preoperatively, and at 1 day, 10 days, 1 month, 3 months, 6 months, and 1 year postoperatively
Using the standard logarithmic visual acuity chart, with units in logMAR.
Time frame: Preoperatively, and at 1 day, 10 days, 1 month, 3 months, 6 months, and 1 year postoperatively
Using the standard logarithmic visual acuity chart, with units in logMAR
Time frame: Preoperatively, and at 1 day, 10 days, 1 month, 3 months, 6 months, and 1 year postoperatively
Spherical diopter (D) is the unit of measurement for the refractive (light-bending) power of a spherical lens (or the spherical component of a corrective lens) used to correct myopia (nearsightedness) or hyperopia (farsightedness).
Time frame: Preoperatively, and at 1 day, 10 days, 1 month, 3 months, 6 months, and 1 year postoperatively
The unit of measurement for the lens power required to correct astigmatism, representing the difference in refractive power between the steepest and flattest meridians (axes) of the eye or lens
Contact information is provided by the study sponsor or research team.
Affiliated Hospital of Nantong University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07481487
Cataract, Cataract Surgery
Bristol, England, United Kingdom
View Trial DetailsNCT05037370
Refractive Surgery
San Antonio, Texas, United States
View Trial DetailsNCT06625749
Eye Diseases, Refractive Error - Myopia
Cleveland, Ohio, United States
View Trial DetailsNCT06448468
Refractive Surgery
Nanchang, Jiangxi, China
View Trial Details